We're Sure It Was the 'Good Intentions' Option | GenomeWeb

TechCrunch wonders where Sergey Brin went. As you may recall, Brin's blog, called too, made a splash when it appeared in September. The second entry on the blog (right after the introductory post) announced that Brin has the LRRK2 gene for familial Parkinson's disease. As TechCrunch's Robin Wauters points out, there was never a third post.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

The Wall Street Journal reports that National Institutes of Health Director Francis Collins' response to contamination concerns at the agency might have delayed care.

The final revision of the Common Rule doesn't include the proposed change requiring consent for leftover biospecimens.

The first Reproducibility Project: Cancer Biology papers show mixed results.

In Nature this week: mobile phone-based targeted DNA sequencing, and more.